Primary Care Clinics in Big Bear Lake, CA Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Bear Valley Community Hospital Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 41870 Garstin Drive, Big Bear Lake, CA 92315 Phone: 909-878-8276 Fax: 909-878-8282 |
Big Bear Family Practice Professional Corporation Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 41945 Big Bear Blvd, Suite 200, Big Bear Lake, CA 92315 Phone: 909-866-6567 |
Cary Stewart Md Inc Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 41820 Garstin Drive, Big Bear Lake, CA 92315 Phone: 909-878-8246 |
The Doctor's House, Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 41870 Garstin Dr, Big Bear Lake, CA 92315 Phone: 678-570-7644 |
David Horner Pc Family Medicine Medicare: Medicare Enrolled Practice Location: 41870 Garstin Dr, Big Bear Lake, CA 92315 Phone: 909-866-6501 |
Bear Mountain Family Practice Family Medicine Medicare: Medicare Enrolled Practice Location: 41945 Big Bear Blvd Ste 200, Big Bear Lake, CA 92315 Phone: 909-866-5868 Fax: 909-866-5860 |
Family Health Center Rhc Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 41820 Garstin Drive, Big Bear Lake, CA 92315 Phone: 909-878-8246 Fax: 909-878-8294 |
News Archive
Failures in Canadian health policy
As America grapples with reforming health care with an eye to introducing a public option, a new book published by the Fraser Institute, one of Canada's leading economic think tanks, details the failures of Canada's government-run health care system and serves as a warning to U.S. policy-makers.
Nobilon initiates a clinical Proof of Concept trial with SCH 900795 vaccine
Nobilon, the human vaccine business unit of Schering-Plough Corporation (NYSE: SGP), today announced that it has initiated a clinical Proof of Concept trial with SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for annual seasonal use.
FDA warns Melanocorp for illegal sale of Melanotan II
The U.S. Food and Drug Administration (FDA) has issued a Warning Letter to Brian Manookian, owner of Melanocorp, Inc. in Hendersonville, Tenn. for the illegal sale and marketing of the product Melanotan II, which is not FDA-approved, on Melanocorp's Web site.
Fallout from Medicaid expansion fights
In Virginia, The Washington Post traces the behind-the-scenes deal-making to create a job for the Democrat state lawmaker whose resignation gave Republicans control of the chamber and the ability to block Gov. Terry McAuliffe's plan to expand Medicaid. Meanwhile, a Missouri hospital lays off 60 employees, blaming the state's failure to expand Medicaid.
EMA CHMP considers AcelRx's ARX-04 for acute pain treatment for centralized review
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04 may be submitted in the European Union (EU) under the Agency's centralized procedure.
› Verified 8 days ago